Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Selby

Showing results (181-190 of 264) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|April 1, 1989
High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseG B Zulian, P Selby, S Milan, et al.
Biochemistry|August 12, 2009
Comparative photochemistry of animal type 1 and type 4 cryptochromesNuri Ozturk, Christopher P Selby, Sang-Hun Song, et al.
British Journal of Cancer|May 1, 1993
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancerU Ward, J N Primrose, P J Finan, et al.
Cancer Biotherapy|January 1, 1993
The impact of interleukin-2 on survival in renal cancer: a multivariate analysisM Jones, T Philip, P Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Nucleotide excision repair removes thymidine analog 5-ethynyl-2'-deoxyuridine from the mammalian genomeLi Wang, Xuemei Cao, Yanyan Yang, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disordersM L Stead, W D Crocombe, L J Fallowfield, et al.
British Journal of Cancer|June 10, 2011
Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRTJ Challberg, L Ashcroft, F Lalloo, et al.
British Journal of Cancer|November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancerD J Kerr, G J Rustin, S B Kaye, et al.
Brain Research. Molecular Brain Research|March 11, 2004
Further evidence for the role of cryptochromes in retinohypothalamic photoreception/phototransductionCarol L Thompson, Christopher P Selby, Carrie L Partch, et al.
Journal of Neurogenetics|April 17, 2003
Pleiotropic effects of cryptochromes 1 and 2 on free-running and light-entrained murine circadian rhythmsRussell N Van Gelder, Therese M Gibler, Daniel Tu, et al.
Pageof 27

Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|April 1, 1989
High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseG B Zulian, P Selby, S Milan, et al.
Biochemistry|August 12, 2009
Comparative photochemistry of animal type 1 and type 4 cryptochromesNuri Ozturk, Christopher P Selby, Sang-Hun Song, et al.
British Journal of Cancer|May 1, 1993
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancerU Ward, J N Primrose, P J Finan, et al.
Cancer Biotherapy|January 1, 1993
The impact of interleukin-2 on survival in renal cancer: a multivariate analysisM Jones, T Philip, P Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Nucleotide excision repair removes thymidine analog 5-ethynyl-2'-deoxyuridine from the mammalian genomeLi Wang, Xuemei Cao, Yanyan Yang, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disordersM L Stead, W D Crocombe, L J Fallowfield, et al.
British Journal of Cancer|June 10, 2011
Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRTJ Challberg, L Ashcroft, F Lalloo, et al.
British Journal of Cancer|November 1, 1995
Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancerD J Kerr, G J Rustin, S B Kaye, et al.
Brain Research. Molecular Brain Research|March 11, 2004
Further evidence for the role of cryptochromes in retinohypothalamic photoreception/phototransductionCarol L Thompson, Christopher P Selby, Carrie L Partch, et al.
Journal of Neurogenetics|April 17, 2003
Pleiotropic effects of cryptochromes 1 and 2 on free-running and light-entrained murine circadian rhythmsRussell N Van Gelder, Therese M Gibler, Daniel Tu, et al.
Pageof 27